Physician profile
Eric Mager
NPI 1447335328
$877.57
in general payments reported to CMS, 2019-2025
19 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.51 · 2020: $88.65 · 2021: $42.30 · 2022: $156 · 2023: $100 · 2024: $131 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $260.94 | 2024-2025 | Novosorb Btm |
| Abbvie INC. | $80.84 | 2023-2024 | |
| Sientra, INC. | $64.87 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $45.80 | 2020-2021 | |
| Tela Bio, INC. | $45.56 | 2024 | Ovitex 2s |
| Allergan, INC. | $45.52 | 2020-2022 | |
| Apyx Medical Corporation | $40.36 | 2019 | |
| Ethicon US, LLC | $38.71 | 2022 | |
| Davol INC. | $38.39 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $27.34 | 2020 | |
| Galderma Laboratories, L.P. | $27.15 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $26.99 | 2024-2025 | |
| Acumed LLC | $23.49 | 2023 | Osteomed, Acumed, Inframe Implant |
| Axogen | $22.46 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Trevena, INC. | $19.64 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $18.23 | 2022 | |
| Merz North America, INC. | $18.15 | 2019 | |
| Mimedx Group, INC. | $16.57 | 2025 | |
| Lilly USA, LLC | $16.56 | 2023 | Taltz, Olumiant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.